What is the initial evaluation for diagnosing hyperaldosteronism vs other adrenal masses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Hyperaldosteronism vs Other Adrenal Masses

For diagnosing hyperaldosteronism versus other adrenal masses, the aldosterone-to-renin ratio (ARR) is the preferred initial test in patients with hypertension and/or hypokalemia, with a value ≥20 ng/dL per ng/mL/hr having excellent sensitivity and specificity (>90%) for confirming hyperaldosteronism. 1

Initial Evaluation for Hyperaldosteronism

Clinical Indicators to Suspect Hyperaldosteronism

  • Hypertension with hypokalemia (spontaneous or diuretic-induced)
  • Resistant hypertension
  • Early-onset hypertension or family history of early-onset hypertension
  • Symptoms such as muscle cramping, weakness, headaches, or intermittent paralysis 2

Laboratory Testing

  1. Aldosterone-to-Renin Ratio (ARR):

    • Must be performed under specific conditions:
      • Morning collection (after patient has been out of bed for 2 hours)
      • Patient seated for 5-15 minutes before collection
      • Patient should be potassium-replete
      • Interfering medications should be discontinued when possible 1
    • Interpretation:
      • ARR ≥20 ng/dL per ng/mL/hr with plasma aldosterone ≥10 ng/dL is considered positive 1, 2
      • Some centers use higher cutoffs (≥30) for increased specificity 2
  2. Confirmatory Testing (if ARR is positive):

    • Intravenous saline suppression test
    • Oral salt-loading test with 24-hour urine aldosterone measurement
    • Fludrocortisone suppression test 1, 2

Imaging

  • Non-contrast CT scan of adrenal glands (or MRI if CT is contraindicated) after biochemical confirmation 2
  • Imaging helps identify adrenal nodules but cannot reliably distinguish between functional and non-functional masses 1

Adrenal Vein Sampling

  • Gold standard for distinguishing between unilateral and bilateral aldosterone production
  • Essential before considering adrenalectomy, particularly in:
    • Patients >40 years old
    • Normal-appearing adrenal glands on imaging
    • Discordance between biochemical and imaging results 2

Differential Diagnosis of Adrenal Masses

1. Cortisol-Secreting Lesions

  • Screening Test: 1 mg overnight dexamethasone suppression test (DST) for all adrenal incidentalomas 1
  • Interpretation:
    • <50 nmol/L excludes cortisol hypersecretion
    • 51-138 nmol/L suggests possible autonomous cortisol secretion
    • 138 nmol/L indicates cortisol hypersecretion 1

  • Additional Testing: Plasma ACTH, 24-hr urinary-free cortisol, midnight salivary cortisol 1

2. Pheochromocytoma

  • Indications for Testing:
    • Adrenal incidentalomas with ≥10 HU on non-contrast CT
    • Signs/symptoms of catecholamine excess (headaches, anxiety attacks, sweating, palpitations) 1
  • Screening Test: Plasma free metanephrines or 24-hour urinary metanephrines 1
  • Interpretation: >2× upper limit of normal is diagnostic 1

3. Adrenocortical Carcinoma

  • Indications for Testing:
    • Suspected ACC
    • Clinical signs of virilization 1
  • Testing: DHEAS, testosterone, and other androgens 1
  • Additional Testing: 17b-estradiol, 17-OH progesterone, androstenedione, 17-OH pregnenolone, 11-deoxycorticosterone, progesterone, and estradiol 1

Management Considerations

For Hyperaldosteronism

  • Unilateral Disease: Laparoscopic adrenalectomy is treatment of choice

    • Improves BP in virtually 100% of patients
    • Complete cure of hypertension in ~50% 1, 2
  • Bilateral Disease or Non-surgical Candidates: Medical therapy with mineralocorticoid receptor antagonists (spironolactone or eplerenone) 1, 2

Important Pitfalls to Avoid

  1. Medication Interference with ARR Testing:

    • Discontinue beta-blockers, centrally acting drugs, diuretics, and mineralocorticoid receptor antagonists when feasible
    • Long-acting calcium channel blockers and alpha-receptor antagonists have minimal interference and can be continued 2
  2. Interpretation Challenges:

    • Very low renin levels can falsely elevate ARR
    • Plasma aldosterone should be at least 10 ng/dL for a positive test 1
    • Consider menstrual cycle timing in females when interpreting ARR 2
  3. Diagnostic Accuracy:

    • Clinical and laboratory data alone cannot reliably differentiate between adenoma and bilateral hyperplasia due to overlap in presentation 3
    • Imaging and adrenal vein sampling are essential for accurate diagnosis 2

By following this systematic approach to evaluating adrenal masses, hyperaldosteronism can be accurately diagnosed and distinguished from other adrenal pathologies, leading to appropriate treatment decisions and improved patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Primary Aldosteronism Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.